CN Patent

CN117357477A — 一种枸橼酸舒芬太尼注射液及其制备方法

Assigned to Shandong University Qilu Hospital Dezhou Hospital Dezhou People's Hospital · Expires 2024-01-09 · 2y expired

What this patent protects

本发明属药物制剂技术领域，具体涉及一种枸橼酸舒芬太尼注射液及其制备方法。本发明枸橼酸舒芬太尼注射液包括：枸橼酸舒芬太尼、2‑氨基乙磺酸、透明质酸钠、pH调节剂、等渗调节剂、注射用水。本发明通过改良配方、改进制备工艺，克服了枸橼酸舒芬太尼见光易分解、在中性或弱碱性条件下不稳定等缺陷，提高了枸橼酸舒芬太尼注射液的稳定性，拓宽了枸橼酸舒芬太尼注射液的pH适用范围。

USPTO Abstract

本发明属药物制剂技术领域，具体涉及一种枸橼酸舒芬太尼注射液及其制备方法。本发明枸橼酸舒芬太尼注射液包括：枸橼酸舒芬太尼、2‑氨基乙磺酸、透明质酸钠、pH调节剂、等渗调节剂、注射用水。本发明通过改良配方、改进制备工艺，克服了枸橼酸舒芬太尼见光易分解、在中性或弱碱性条件下不稳定等缺陷，提高了枸橼酸舒芬太尼注射液的稳定性，拓宽了枸橼酸舒芬太尼注射液的pH适用范围。

Drugs covered by this patent

Patent Metadata

Patent number
CN117357477A
Jurisdiction
CN
Classification
—
Expires
2024-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Shandong University Qilu Hospital Dezhou Hospital Dezhou People's Hospital
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.